$RichWire Markets and money, explained simply

LIVE

08:35 Artificial Intelligence Dominates Market Focus Once Again 08:29 Nvidia Shares Slide as CEO Jensen Huang Resigns Following Scandal 08:25 Embraer Maintains Buy Rating Following Third-Quarter Performance 08:23 Anthropic Targets $1.4 Trillion Valuation in Upcoming Nasdaq Debut 08:20 Lowe's Positioned for Growth Amid Expanding Home Remodeling Budgets 07:39 Examining OMS Energy Technologies: Balance Sheet Strength and Growth Prospects 07:35 NextEra Energy Emerges as Value Opportunity Amid Utility Sector Pullback 07:34 Carlsmed and the Upcoming Reimbursement Reset 07:32 Evaluating the Risk-Reward Profile of BlackRock MuniHoldings California Quality Fund 07:29 BorgWarner Shifts Propulsion Expertise Toward Data Centers and Industrial Power 07:29 Jenoptik Reports Double-Digit Revenue Growth Amid Semiconductor Surge 07:27 Evaluating Self-Storage Resilience Through CubeSmart's Third-Quarter Results 08:35 Artificial Intelligence Dominates Market Focus Once Again 08:29 Nvidia Shares Slide as CEO Jensen Huang Resigns Following Scandal 08:25 Embraer Maintains Buy Rating Following Third-Quarter Performance 08:23 Anthropic Targets $1.4 Trillion Valuation in Upcoming Nasdaq Debut 08:20 Lowe's Positioned for Growth Amid Expanding Home Remodeling Budgets 07:39 Examining OMS Energy Technologies: Balance Sheet Strength and Growth Prospects 07:35 NextEra Energy Emerges as Value Opportunity Amid Utility Sector Pullback 07:34 Carlsmed and the Upcoming Reimbursement Reset 07:32 Evaluating the Risk-Reward Profile of BlackRock MuniHoldings California Quality Fund 07:29 BorgWarner Shifts Propulsion Expertise Toward Data Centers and Industrial Power 07:29 Jenoptik Reports Double-Digit Revenue Growth Amid Semiconductor Surge 07:27 Evaluating Self-Storage Resilience Through CubeSmart's Third-Quarter Results

Topic: First Defense

ImmuCell Shifts Focus to First Defense Line, Ramps Up Capacity Amid Strong Calf Demand

Companies10 h ago

ImmuCell Shifts Focus to First Defense Line, Ramps Up Capacity Amid Strong Calf Demand

ImmuCell reported third-quarter 2026 financial results highlighting a strategic shift toward its First Defense product line and an $8 million capital expansion project to…

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.